Literature DB >> 22146206

Lower-limb amputations in patients with diabetes mellitus.

Alejandro E Pino1, Samantha Taghva, Cary Chapman, John H Bowker.   

Abstract

It is estimated that approximately 23.6 million people in the United States have diabetes mellitus. With adequate control of this disease and appropriate foot care and basic surveillance, many patients can lead active and healthy lifestyles. However, some patients experience complications associated with poorly controlled glucose levels, including lower-extremity ulcerations and infections. When conservative measures have failed in treating these conditions, a lower-extremity amputation is an option for patients seeking to gain maximal functional recovery. A complete preoperative workup includes assessment of healing potential and preoperative ambulatory status, control or optimization of comorbidities when possible, and determination of amputation level using modern diagnostic modalities. Once the decision to proceed with an amputation has been made, it is important to choose an appropriate level of amputation and practice sound surgical technique. This article describes the preoperative evaluation and operative techniques involved in performing amputations on diabetic patients and reviews the current literature on the most common lower-extremity amputations performed in the care of infections in the feet of patients with diabetes mellitus.
Copyright © 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 22146206     DOI: 10.3928/01477447-20111021-16

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Management of diabetic foot ulcer in Babol, North of Iran: an experience on 520 cases.

Authors:  Nasser Janmohammadi; Mohammad Reza Hasanjani Roshan; Mohammad Rouhi; Sayed Mokhtar Esmailnejad Ganji; Masoud Bahrami; Zolaika Moazezi
Journal:  Caspian J Intern Med       Date:  2012

2.  Antioxidant and Antimicrobial Potentials of Seed Oil from Carthamus tinctorius L. in the Management of Skin Injuries.

Authors:  Ikram Khémiri; Badiaa Essghaier; Najla Sadfi-Zouaoui; Lotfi Bitri
Journal:  Oxid Med Cell Longev       Date:  2020-11-04       Impact factor: 6.543

3.  Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot.

Authors:  Matevž Kastrin; Vilma Urbančič Rovan; Igor Frangež
Journal:  J Clin Med       Date:  2021-03-15       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.